Author

A Sharma

Johns Hopkins UniversityORCID 0000-0003-1361-6923Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Ajay Sharma2 papers · University of Mississippi

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Organism:fungi (other)· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

Kuldeep GuptaiD· 2 shared Sridhar NimmagaddaiD· 2 shared Akhilesh Mishra· 1 shared Akhilesh MishraiD· 1 shared Anusha Gaddam· 1 shared Burles Avner JohnsoniD· 1 shared David James McConkeyiD· 1 shared Debatrayee Sinha· 1 shared

Activity by Year

2026-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Kuldeep GuptaORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cell BiologybioRxivPreprintJul 29, 2026

Calmodulin requires Ca2+ to integrate into the spindle pole body and modulate the cytokinetic ring constriction in fission yeast cells

Marium Zehra, Debatrayee Sinha, A Sharma…·Qian Chen

DOI 10.64898/2026.05.08.723810

fungi (other)proteomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJun 23, 2026

SuFEx and macrocyclic chelation define orthogonal reactivity domains enabling isotopically versatile radiopharmaceuticals from a single peptide precursor

A Sharma, Akhilesh Mishra, Kuldeep Gupta, Sridhar Nimmagadda

This paper introduces a method using SuFEx chemistry and macrocyclic chelation to enable isotopically versatile radiopharmaceuticals from a single peptide precursor.

DOI 10.64898/2026.05.27.728245

experimental assaydrug response / drug discovery

𝕏 PostBluesky

Cancer BiologyScience AdvancesPeer-reviewedJan 7, 2026

Nectin-4 PET For Optimizing Enfortumab Vedotin Dose-Response In Urothelial Carcinoma

Akhilesh Mishra, Ajay Sharma, Kuldeep Gupta…·Sridhar Nimmagadda

This paper uses Nectin-4 PET imaging to assess target engagement and optimize dosing of enfortumab vedotin in urothelial carcinoma, finding that PET metrics better predict therapeutic response than dose or baseline expression.

17 citationstop 1%

𝕏 PostBluesky